+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

RNA Analysis / Transcriptomics - Global Market Trajectory & Analytics

  • ID: 4806333
  • Report
  • March 2022
  • Region: Global
  • 504 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • CD Genomics
  • F. Hoffmann-La Roche Ltd.
  • GenXPro GmbH
  • Illumina, Inc.
  • LC Sciences
  • Merck KGaA

Global RNA Analysis / Transcriptomics Market to Reach US$10.5 Billion by the Year 2026


Transcriptomics is the study of the RNA transcripts set produced by the organism's genome. Transcriptome analysis enables researchers to understand DNA's sequence as well as its functioning. The gene expression patterns` increased demand for specific genes, various assay technologies, quantification of multiplexed RNA, increased requirement for genetic testing and personalized medicine, rise in genetic variation and genetic mutation incidences boost the transcriptomics technologies market demand. Additionally, continuous technological developments in products increased commercialization, and increasing disease cases such as hepatitis B, diabetes, and cancer, too, propel the transcriptomics technologies market growth. Pharmaceutical and biotechnology companies` R&D funding, increased demand for compact and reliable products, too, are the other key factors anticipated to drive market growth. Innovations and new product launches are also projected to fuel the growth over the analysis period. For instance, NuGEN Technologies, Inc.'s Trio RNA-Seq, which provides a highly sensitive end-to-end transcriptomics solution, is ideal for use in low abundance transcripts applications. The innovative Trio RNA-Seq technique integrates three powerful technologies, including single primer isothermal amplification (SPIA); AnyDeplete, for use in high sensitivity ribonucleic acid (RNA) analysis; and DimerFree. The increase in grants and funding by various government and private organizations is another factor fueling growth within the market.

Amid the COVID-19 crisis, the global market for RNA Analysis / Transcriptomics estimated at US$6.5 Billion in the year 2022, is projected to reach a revised size of US$10.5 Billion by 2026, growing at a CAGR of 14.1% over the analysis period. Reagents / Consumables, one of the segments analyzed in the report, is projected to grow at a 15.4% CAGR to reach US$5.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 12.5% CAGR for the next 7-year period. This segment currently accounts for a 30.1% share of the global RNA Analysis / Transcriptomics market.

The U.S. Market is Estimated at $2.6 Billion in 2022, While China is Forecast to Reach $891.5 Million by 2026


The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$2.6 Billion in the year 2022. The country currently accounts for a 39.34% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$891.5 Million in the year 2026 trailing a CAGR of 15.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR while Rest of European market (as defined in the study) will reach US$1 Billion by the end of the analysis period. North America represents the most dominant region because of the presence of a large number of biotech companies having well-established infrastructure and state-of-the-art technological platforms. Growing opportunities, increasing healthcare expenditure, and the introduction of government initiatives are the other factors driving market growth. Additionally, the sustained increase in transcriptomics-related research and development investments by the private sector is enabling the regional market players to develop targeted therapeutics.

Services Segment to Reach $2 Billion by 2026


In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$744.8 Million will reach a projected size of US$1.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$130.8 Million by the year 2026.

Select Competitors (Total 115 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • F. Hoffmann-La Roche Ltd.
  • GenXPro GmbH
  • Illumina, Inc.
  • LC Sciences
  • Merck KGaA
  • Qiagen N.V.
  • Sequentia Biotech SL
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the publisher's digital archives and Research Platform
  • Complimentary updates for one year
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • CD Genomics
  • F. Hoffmann-La Roche Ltd.
  • GenXPro GmbH
  • Illumina, Inc.
  • LC Sciences
  • Merck KGaA

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of COVID-19 Pandemic and Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed?
  • Pandemic Impact on RNA Analysis/Transcriptomics Market
  • RNA-Oriented Projects Set to Increase
  • Competition
  • EXHIBIT 1: RNA Analysis / Transcriptomics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 44 Players Worldwide in 2022 (E)
  • What is RNA-Seq Technology?
  • A Prelude to Transcriptomics Technologies
  • Global Market Prospects & Outlook
  • PCR Emerges as the Leading Technology
  • Drug Discovery Segment Poised to Lead the Global Market
  • North America Emerges as the Major Regional Market
  • World Brands
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Trend Towards Personalized Medicine Fuels Market Growth
  • EXHIBIT 2: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
  • EXHIBIT 3: World Personalized Medicine Market by Region/Country (2021)
  • EXHIBIT 4: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
  • EXHIBIT 5: Number of Available Personalized Medicines in the US (2010-2020)
  • EXHIBIT 6: Personalized Medicines as % of New FDA Drug Approvals for 2015-2021
  • Transcriptomics Assume Critical Importance amid Growing Prevalence of Chronic Diseases
  • EXHIBIT 7: World Diabetes and Population Statistics (2021, 2030 & 2045)
  • EXHIBIT 8: World Diabetes Prevalence (2000-2045)
  • EXHIBIT 9: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • EXHIBIT 10: Global HIV Prevalence: Number of People Living with AIDs (in Million) by Region as of June 2021
  • EXHIBIT 11: Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
  • Transcriptomics Applications in Disease and Diagnostic Profiling
  • Increasing PCR Applications in Biotechnology Sector
  • Progressive Growth of Omics Technologies: Opportunity for RNA Analysis/ Transcriptomics Market
  • The Growing Role of Transcriptomics in Oncology
  • EXHIBIT 12: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • EXHIBIT 13: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
  • EXHIBIT 14: Number of New Cancer Cases and Deaths (in Million) by Region for 2020
  • RNA Sequencing Critical for Cancer and Rare Diseases
  • Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiovascular Research
  • Bulk RNA Sequencing
  • Single-Cell Sequencing
  • Spatial Transcriptomics
  • Single-Cell RNA-seq Technologies Witness Steady Growth
  • The Evolution of scRNA-seq
  • Growth of Long-Read Transcriptome Sequencing
  • scRNA-seq for Autoimmune Inflammatory Rheumatic Diseases
  • SPLiTseq Beneficial for Understanding Cause of Disease
  • Gene Expression Microarray Technology Gains Ground
  • Microfluidics-based Droplet Technologies Demonstrate Growth
  • inDrops Approach Exhibits Growth
  • Spatial Transcriptomics Market Witnesses Significant Growth
  • Spatial Transcriptomic Data Analysis
  • Next Generation Sequencing Offers Increased Accuracy for Transcriptomics Activity
  • Single-cell NGS Witnesses Rapid Growth
  • RNA Sequencing Benefits Fuel Market Prospects
  • Blood Transcriptome Sequencing for Identifying Rare-Disease Genes
  • Rising Focus on Toxicogenomics: Potential for RNA Analysis/Transcriptomics Markets
  • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
  • EXHIBIT 15: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
  • EXHIBIT 16: R&D Spending as % of Revenues in Select Leading Pharmaceutical Companies (2020)
  • EXHIBIT 17: R&D Spending (in US$ Billion) of Select Leading Biotechnology Companies for 2020
  • Technological Advancements & Innovations Fuel Market Growth
  • Sci-Plex - A New Technique to Profile Gene Expression within Single Cells
  • Introduction of Oxford Nanopore’s Innovative Portable Sequencer for Sequencing Long Reads and RNA Molecules Improves Transcriptomic Analysis
  • RNA-Combine, a Toolkit for More Comprehensively Analyzing Transcriptome Data
  • Aging Demographics Present Opportunities for Transcriptomics Technologies
  • EXHIBIT 18: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • EXHIBIT 19: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Challenges Facing RNA/Transcriptomics Market

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Market Analytics

CANADA


JAPAN

CHINA

  • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Analytics

EUROPE

  • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Analytics

FRANCE


GERMANY


ITALY


UNITED KINGDOM


REST OF EUROPE

ASIA-PACIFIC

  • RNA Analysis / Transcriptomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Market Analytics

REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 115
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • F. Hoffmann-La Roche Ltd.
  • GenXPro GmbH
  • Illumina, Inc.
  • LC Sciences
  • Merck KGaA
  • Qiagen N.V.
  • Sequentia Biotech SL
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Note: Product cover images may vary from those shown